Proofstock
DashboardScreenerTrack RecordMethodology
DashboardScreenerTrack RecordMethodology
Proofstock
DashboardScreenerTrack RecordMethodology

Proofstock provides quantitative ratings and research based on a transparent six-factor methodology. These ratings are research products, not investment recommendations. We are not a Registered Investment Advisor, and nothing on this site constitutes personalized investment advice. Past performance does not guarantee future results. Consult a licensed financial advisor before making investment decisions.

Proofstock
DashboardScreenerTrack RecordMethodology
As of
July 13, 2026
DashboardScreenerTrack RecordMethodology
← Dashboard

CYTK

Strong Bullish

Cytokinetics, Incorporated

Healthcare · Biotechnology · $9.44B market cap

Last close
$82.24
-3.10% · 1 day
as of Jul 13, 2026
60-day price history
Rating
Strong Bullish98thpercentile
Ranks #7 of 194 in Healthcare

Among the highest-conviction names in the universe on the composite score. Ranks in the 98th percentile overall.

Factor breakdown

Momentum
Quality
Value
Growth
Size
Low Volatility

What this stock is good at

  • Growth

What this stock is not strong at

Nothing notable on this side.

Rating history

Last 27 scored days
Proofstock
DashboardScreenerTrack RecordMethodology

Proofstock provides quantitative ratings and research based on a transparent six-factor methodology. These ratings are research products, not investment recommendations. We are not a Registered Investment Advisor, and nothing on this site constitutes personalized investment advice. Past performance does not guarantee future results. Consult a licensed financial advisor before making investment decisions.

May 17, 2026 · 83rdJul 13, 2026 · 98th

Recent factor inputs

The latest raw values feeding the six factors.

P/E
-9.9×
P/B
-9.8×
EV/EBITDA
-54.8×
FCF yield
—
ROE
24.9%
ROIC
-16.1%
Debt / equity
-1.56
Rev growth 3Y
450.6%
EPS growth 3Y
-29.1%
12-1 return
83.3%
3M return
26.5%
Realized vol
56.4%